Efficacy of an Assisted Therapy Optimizing Module to Improve Physician Adherence
Recruiting · NCT06714344 · Interventional (participants receive a specific treatment) · Lead sponsor: Medical University Innsbruck
View the official record on ClinicalTrials.gov →Interventions studied
KITGuideMe: W61-MD41-AIT, version 1.0.0
What this trial is about
Heart failure patients within the HM programme
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- AMPEL, CIP, Version: 1.2 Date: 27.03.2024
- Written, signed and dated informed consent for inclusion in the HM programme
- Male and female patients over 18 years of age.
- Hospitalised for decompensated heart failure requiring intravenous diuretics
- Need for iv diuresis in nonhospital setting because of impending hospitalization for cardiac decompensation
Exclusion criteria
- Multimorbidity (Charlson Comorbidity Index \> 6)
- Dementia
- Lack of willingness to participate
Where it is running
2 locations listed.
- Medical University of Graz, University Hospital for Internal Medicine (Cardiology) - Graz, Styria, Austria
- Medical University of Innsbruck, University Hospital for Internal Medicine III (Cardiology and Angiology) - Innsbruck, Tyrol, Austria